---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-072288"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2023-08-30T23:59:59+00:00"
generated_at: "2026-06-11T02:07:44.665861+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Longevity Biomedical waives $30M minimum cash condition for Denali merger

## Summary
- Longevity irrevocably waived the $30M minimum cash condition in the merger agreement with Denali Capital Acquisition Corp.
- Waiver effective August 29, 2023; removes a key closing condition for the business combination.
- Merger agreement originally signed Jan 25, 2023, amended April 11, 2023.
- Parties include Denali, Longevity, Holdco, Merger Subs, and seller representative Bradford A. Zakes.

## SEC filing metadata
- accession: 0001213900-23-072288
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2023-08-30T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390023072288/0001213900-23-072288-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390023072288/ea184480-8k425_denalicap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-072288
- JSON: https://secwatch.observer/filing/0001213900-23-072288.json
- Plain text: https://secwatch.observer/filing/0001213900-23-072288.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.